Butcher's Broom is a Mediterranean shrub whose root extract is used to maintain leg vein tone and ease leg swelling, heaviness, and cramping. Medium-level, largely industry-funded evidence shows oral extracts reduce leg swelling and vein discomfort, mostly in formulas with citrus compounds and vitamin C. Single-herb oral use matches placebo tolerability, while combination formulas carry a rare risk of reversible colon inflammation and watery diarrhea. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Ankle and Calf Circumference / Lower-Limb Volume | No established target; reduction from baseline (e.g., −16.5 to −20.5 mL leg volume or −0.58 cm ankle circumference) | Efficacy marker: expected to decrease as venous tone and capillary sealing improve. |
| Seated and Standing Blood Pressure | No established target; seated and standing blood pressure change from individual baseline | Safety check and efficacy marker: detects unwanted arterial pressor shifts or improved orthostatic stability. |
| Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) | 10–40 U/L (ALT); 10–35 U/L (AST) (standard reference range) | Safety check: detects rare drug-induced cytolytic hepatitis (liver cell injury); enzyme elevation above reference range prompts cessation. |
| Fasting Plasma Glucose, Serum Potassium, and Bicarbonate | 70–99 mg/dL (glucose); 3.5–5.0 mmol/L (potassium); 22–29 mmol/L (bicarbonate) (standard reference range) | Safety check: detects elevated blood glucose, ketoacidosis (ketone acid buildup), high potassium, or diarrhea-induced low potassium prompting cessation. |
Cadence: Baseline evaluation before starting; blood pressure and fasting glucose at 1–2 weeks; limb circumference and venous symptoms at 4, 8, and 12 weeks; liver transaminases and serum electrolytes at 4–8 weeks (then every 3–6 months during seasonal cycles), or immediately if persistent watery diarrhea or systemic symptoms develop.